Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 149
Filter
1.
Sci Rep ; 12(1): 504, 2022 01 11.
Article in English | MEDLINE | ID: mdl-35017615

ABSTRACT

We provide a descriptive characterization of the unfolded protein response (UPR) in skeletal muscle of human patients with peritoneal sepsis and a sepsis model of C57BL/6J mice. Patients undergoing open surgery were included in a cross-sectional study and blood and skeletal muscle samples were taken. Key markers of the UPR and cluster of differentiation 68 (CD68) as surrogate of inflammatory injury were evaluated by real-time PCR and histochemical staining. CD68 mRNA increased with sepsis in skeletal muscle of patients and animals (p < 0.05). Mainly the inositol-requiring enzyme 1α branch of the UPR was upregulated as shown by elevated X-box binding-protein 1 (XBP1u) and its spliced isoform (XBP1s) mRNA (p < 0.05, respectively). Increased expression of Gadd34 indicated activation of PRKR-Like Endoplasmic Reticulum Kinase (PERK) branch of the UPR, and was only observed in mice (p < 0.001) but not human study subjects. Selected cell death signals were upregulated in human and murine muscle, demonstrated by increased bcl-2 associated X protein mRNA and TUNEL staining (p < 0.05). In conclusion we provide a first characterization of the UPR in skeletal muscle in human sepsis.


Subject(s)
Endoplasmic Reticulum Stress , Muscle, Skeletal/metabolism , Peritoneal Diseases/physiopathology , Sepsis/physiopathology , Unfolded Protein Response , Aged , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/genetics , Antigens, Differentiation, Myelomonocytic/metabolism , Female , Humans , Male , Mice , Mice, Inbred C57BL , Middle Aged , Peritoneal Diseases/genetics , Peritoneal Diseases/metabolism , Protein Phosphatase 1/genetics , Protein Phosphatase 1/metabolism , Sepsis/genetics , Sepsis/metabolism , X-Box Binding Protein 1/genetics , X-Box Binding Protein 1/metabolism
2.
Reprod Biomed Online ; 43(3): 370-378, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34272164

ABSTRACT

Endometriosis is a chronic oestrogen-dependent gynaecological disorder characterized by non-menstrual pelvic pain, infertility and the extrauterine growth of endometrial-like glands and stroma. It has been noted that the eutopic endometrium of women with endometriosis is functionally distinct from that of women without endometriosis. Moreover, ectopic endometrial implants are functionally different from the eutopic endometrium of women with endometriosis. However, the mechanisms directing these differences are ill-defined. It is proposed here that small membrane-bound extracellular vesicles called exosomes are important vehicles in the protection and transport of signalling molecules central to the dysregulation of endometrial function in women with endometriosis. Therefore, a critical review of the literature linking exosomes and their cargo to the pathobiology of endometriosis was conducted. Circulating peritoneal fluid and endometrial cell exosomes contained long non-coding RNA, miRNA and proteins involved in histone modification, angiogenesis and immune modulation that differed significantly in women with endometriosis compared with controls. Moreover, experimental evidence supports a role for exosomes and their cargo in angiogenesis, neurogenesis, immune modulation and endometrial stromal cell invasion. It is therefore suggested that exosomes play an important role in the pathophysiology of endometriosis.


Subject(s)
Endometriosis/physiopathology , Endometrium/physiology , Exosomes/physiology , Peritoneal Diseases/physiopathology , Endometriosis/genetics , Endometriosis/metabolism , Endometriosis/pathology , Endometrium/cytology , Epithelial Cells/physiology , Exosomes/metabolism , Female , Humans , Immune System/physiopathology , MicroRNAs/metabolism , MicroRNAs/physiology , Neovascularization, Pathologic/physiopathology , Peritoneal Diseases/genetics , Peritoneal Diseases/metabolism , Peritoneal Diseases/pathology , Proteins/metabolism , Proteins/physiology , RNA, Untranslated/metabolism , RNA, Untranslated/physiology , Stromal Cells/physiology
3.
Emerg Radiol ; 28(1): 201-207, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32712870

ABSTRACT

The term intraperitoneal focal fat infarction (IFFI) includes various self-limiting clinical conditions that are caused by focal fatty tissue necrosis. Most of the cases of IFFI concern torsion or infarction of the greater omentum or the epiploic appendages. However, although rarely, perigastric ligaments can also undergo torsion also leading to fat infarction. IFFI clinically may mimic other pathologies, such as acute appendicitis or diverticulitis, making their clinical diagnosis a challenge. Ultrasound (US) and computed tomography (CT) have a high sensitivity and specificity for the diagnosis of IFFI excluding other pathologies, and in most cases, the clinical evolution is spontaneously favorable, thus helping to reduce the need for unnecessary surgical intervention. We review cases with IFFI in order to identify specific involvement patterns. Cases of epiploic appendages reported to an acute, subacute, and more chronic phase in order to present the self-limiting nature of this entity and the resultant absorption. We also present cases with falciform ligament infarction, as well as primary ("whirl sign" on CT due to greater omentum torsion) and secondary omental infarctions. The aim of this pictorial review is not only to extensively explore the imaging findings of IFFI but to also describe the clinical presentation and pathophysiology of the prementioned conditions.


Subject(s)
Abdomen, Acute/diagnostic imaging , Adipose Tissue/diagnostic imaging , Infarction/diagnostic imaging , Peritoneal Diseases/diagnostic imaging , Torsion Abnormality/diagnostic imaging , Abdomen, Acute/physiopathology , Diagnosis, Differential , Humans , Infarction/physiopathology , Necrosis , Peritoneal Diseases/physiopathology , Tomography, X-Ray Computed , Torsion Abnormality/physiopathology , Ultrasonography
4.
J Minim Invasive Gynecol ; 28(2): 325-331, 2021 02.
Article in English | MEDLINE | ID: mdl-32615330

ABSTRACT

STUDY OBJECTIVE: To assess the feasibility of a noncontact radio sensor as an objective measurement tool to study postoperative recovery from endometriosis surgery. DESIGN: Prospective cohort pilot study. SETTING: Center for minimally invasive gynecologic surgery at an academically affiliated community hospital in conjunction with in-home monitoring. PATIENTS: Patients aged above 18 years who sleep independently and were scheduled to have laparoscopy for the diagnosis and treatment of suspected endometriosis. INTERVENTIONS: A wireless, noncontact sensor, Emerald, was installed in the subjects' home and used to capture physiologic signals without body contact. The device captured objective data about the patients' movement and sleep in their home for 5 weeks before surgery and approximately 5 weeks postoperatively. The subjects were concurrently asked to complete a daily pain assessment using a numeric rating scale and a free text survey about their daily symptoms. MEASUREMENTS AND MAIN RESULTS: Three women aged 23 years to 39 years and with mild to moderate endometriosis participated in the study. Emerald-derived sleep and wake times were contextualized and corroborated by select participant comments from retrospective surveys. In addition, self-reported pain levels and 1 sleep variable, sleep onset to deep sleep time, showed a significant (p <.01), positive correlation with next-day-pain scores in all 3 subjects: r = 0.45, 0.50, and 0.55. In other words, the longer it took the subject to go from sleep onset to deep sleep, the higher their pain score the following day. CONCLUSION: A patient's experience with pain is challenging to meaningfully quantify. This study highlights Emerald's unique ability to capture objective data in both preoperative functioning and postoperative recovery in an endometriosis population. The utility of this uniquely objective data for the clinician-patient relationship is just beginning to be explored.


Subject(s)
Endometriosis/surgery , Inventions , Laparoscopy/rehabilitation , Minimally Invasive Surgical Procedures/rehabilitation , Monitoring, Physiologic/methods , Peritoneal Diseases/surgery , Sleep/physiology , Adult , Biosensing Techniques/methods , Endometriosis/physiopathology , Endometriosis/rehabilitation , Female , Humans , Pain Measurement , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology , Peritoneal Diseases/physiopathology , Peritoneal Diseases/rehabilitation , Pilot Projects , Postoperative Period , Prospective Studies , Retrospective Studies , Surveys and Questionnaires , Telemedicine/instrumentation , Telemedicine/methods , Wireless Technology , Young Adult
5.
Gynecol Endocrinol ; 36(11): 1015-1023, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32880200

ABSTRACT

AIM: To systematically compare sexual function between non-treated women with and without endometriosis. METHODS: A systematic review was performed on PubMed/Medline, Scopus, EMBASE, Web of Science and Cochrane Library databases searching studies that analyzed sexual function (assessed with the 19-item Female Sexual Function Index [FSFI]), and dyspareunia, chronic pelvic pain and dysmenorrhea (assessed with a visual analogue scale [VAS]) in women with and with endometriosis. RESULTS: In 4 studies, non-treated women with endometriosis presented a higher risk of female sexual dysfunction (mean total FSFI score ≤ 26.55; OR = 2.38; 95% confidence interval [CI] = 1.12, 5.04). Although mean total FSFI scores were not significantly different between women with and without endometriosis (mean difference [MD] = -2.15; 95% CI -4.96, 0.67); all FSFI domain scores were significantly lower in women with endometriosis (n = 4 studies): desire (MD = -0.43; 95% CI -0.57, -0.19); arousal (MD = -0.66; 95% CI -1.15, -0.17); lubrication (MD = -0.41; 95% CI -0.79, -0.02); orgasm (MD = -0.40; 95% CI -0.73, -0.06); satisfaction (MD = -0.45; 95% CI -0.72, -0.18); and pain (MD = -1.03; 95% CI -1.34, -0.72). Women with endometriosis displayed differences (more severity) in terms of VAS scores (2 studies) for dyspareunia (MD = 1.88; 95% CI 0.38, 3.37) and chronic pelvic pain (MD = 2.92; 95% CI 1.26, 4.58); but not for dysmenorrhea. CONCLUSION: Non-treated women with endometriosis displayed altered sexual function as evidenced by lower scores in all FSFI domains, and severity of dyspareunia and chronic pelvic pain.


Subject(s)
Endometriosis/complications , Health Status Indicators , Peritoneal Diseases/complications , Sexual Dysfunction, Physiological/diagnosis , Sexual Dysfunction, Physiological/etiology , Adult , Chronic Pain/epidemiology , Chronic Pain/etiology , Chronic Pain/physiopathology , Chronic Pain/psychology , Dysmenorrhea/complications , Dysmenorrhea/epidemiology , Dysmenorrhea/physiopathology , Dysmenorrhea/psychology , Dyspareunia/diagnosis , Dyspareunia/epidemiology , Dyspareunia/etiology , Dyspareunia/psychology , Endometriosis/epidemiology , Endometriosis/physiopathology , Endometriosis/psychology , Female , Humans , Orgasm/physiology , Pelvic Pain/epidemiology , Pelvic Pain/etiology , Pelvic Pain/physiopathology , Pelvic Pain/psychology , Peritoneal Diseases/epidemiology , Peritoneal Diseases/physiopathology , Peritoneal Diseases/psychology , Personal Satisfaction , Sexual Dysfunction, Physiological/epidemiology , Surveys and Questionnaires
6.
Reprod Biol Endocrinol ; 18(1): 63, 2020 Jun 12.
Article in English | MEDLINE | ID: mdl-32532293

ABSTRACT

BACKGROUND: A large body of research highlights the importance of early-life environmental impact on the health outcome in adulthood. However, whether early-life adversity (ELA) has any impact on the development of endometriosis is completely unclear. In this study, we tested the hypothesis that ELA, as manifested by neonatal separation, can accelerate the progression of endometriosis in mouse through activation of the adrenergic receptor ß2 (ADRB2) signaling pathway, leading to increased angiogenesis and progression of endometriotic lesions. METHODS: Eight female Balb/C mice, in late pregnancy, were used used for this study, which later gave birth to 22 female newborn pubs. Eleven additional female Balb/C mice were also used as donors of uterine tissues. The 22 newborn pubs were randomly divided into 2 equal-sized groups, maternal separation (MS) and no separation (NS). Pubs in the MS group were separated from their dams for 3 h/day from postnatal day (PND) 1 to 21, while those in the NS control remained in the home cage with their dams. In adulthood (8-week old), 3 mice in each group were randomly selected to undergo a battery of behavior tests. The remaining 8 mice in each group were induced with endometriosis by intraperitoneal injection of uterine fragments from donor mice. Four weeks after the induction, all mice were sacrificed and their endometriotic lesions were excised for quantification and then prepared for immunohistochemistry analysis. RESULTS: We confirmed that MS during infancy resulted in anxiety and depression-like behaviors as previously reported. We also found that in MS mice the lesion weight was increased by over 2 folds and generalized hyperalgesia was also significantly increased as compared with NS mice. Immunostaining analysis demonstrated that MS accelerated the development of endometriosis likely through decreased dopamine receptor D2 (DRD2) expression and activation of the ADRB2/cAMP-response element binding protein (CREB) signaling pathway, leading to increased angiogenesis and progression of endometriotic lesions. CONCLUSIONS: Exposure of female mouse pups to ELA such as MS during their infancy period accelerates the progression of endometriosis, possibly through altered neuronal wiring and hyperactivity of the hypothalamic-pituitary-adrenal axis.


Subject(s)
Endometriosis , Hyperalgesia , Maternal Deprivation , Peritoneal Diseases , Receptors, Adrenergic, beta-2 , Animals , Female , Mice , Animals, Newborn , Anxiety/psychology , Behavior, Animal , Cyclic AMP Response Element-Binding Protein/metabolism , Depression/psychology , Disease Models, Animal , Disease Progression , Endometriosis/metabolism , Endometriosis/pathology , Endometriosis/physiopathology , Endometriosis/psychology , Hyperalgesia/metabolism , Hyperalgesia/physiopathology , Hyperalgesia/psychology , Hypothalamo-Hypophyseal System/metabolism , Injections, Intraperitoneal , Mice, Inbred BALB C , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Neovascularization, Pathologic/physiopathology , Peritoneal Diseases/metabolism , Peritoneal Diseases/pathology , Peritoneal Diseases/physiopathology , Peritoneal Diseases/psychology , Pituitary-Adrenal System/metabolism , Random Allocation , Receptors, Adrenergic, beta-2/metabolism , Receptors, Dopamine D2/metabolism , Signal Transduction , Uterus/transplantation , Stress, Psychological
7.
Mol Hum Reprod ; 25(9): 550-561, 2019 09 01.
Article in English | MEDLINE | ID: mdl-31323679

ABSTRACT

Fibrotic tissue may contribute to the origin of some endometriosis-related symptoms, such as chronic pelvic pain and infertility. Alterations in the H19/miR-216a-5p/ACTA2 pathway may mediate the regulation of eutopic endometrial stromal cell (euESC) invasion and migration and may represent a potential mechanism underlying fibrous tissue formation or fibrosis in women with endometriosis. In this study, we aimed to determine the expression of H19 and ACTA2 in endometrial tissues of women with endometriosis. Two groups of 23 infertile women with endometriosis and 23 matched infertile women without endometriosis were investigated. Primary cultured cells of endometrial tissues were analyzed using RT-PCR and western blotting (WB) to determine expression of H19 and ACTA2. 5-Ethyl-2'-deoxyuridine, CCK8 and Transwell assays were used to study the functions of H19 and ACTA2. Human embryonic kidney 293 cells were used for luciferase assays to study miR-216a-5p binding sites with H19 and ACTA2. We found that H19 and ACTA2 levels were significantly higher in endometriosis euESCs than in control euESCs (P < 0.05) and were positively correlated in endometriosis euESCs. Luciferase assays indicated that H19 regulates ACTA2 expression via competition for inhibitory miR-216a-5p binding sites. Our results indicate that alterations in the estrogen/H19/miR-216a-5p/ACTA2 pathway regulated endometriosis euESC invasion and migration. Downregulation of H19 or ACTA2 inhibited endometriosis euESC invasion and migration; however, estrogen promoted endometriosis euESC invasion and migration via H19. The main limitation of our study was that experiments were conducted in vitro and further in vivo studies are required in the future. However, our study showed that primary cultured cells represented endometriosis cells more clearly than cell lines.


Subject(s)
Actins/physiology , Endometriosis , Estradiol/pharmacology , MicroRNAs/genetics , Peritoneal Diseases , RNA, Long Noncoding/genetics , Stromal Cells/physiology , Adult , Case-Control Studies , Cell Adhesion/drug effects , Cell Adhesion/genetics , Cell Movement/drug effects , Cell Movement/genetics , Cells, Cultured , Endometriosis/genetics , Endometriosis/pathology , Endometriosis/physiopathology , Endometrium/metabolism , Endometrium/pathology , Female , Gene Expression Regulation/drug effects , HEK293 Cells , Humans , Infertility, Female/genetics , Infertility, Female/pathology , MicroRNAs/drug effects , Peritoneal Diseases/genetics , Peritoneal Diseases/pathology , Peritoneal Diseases/physiopathology , Primary Cell Culture , RNA, Long Noncoding/drug effects , Signal Transduction/drug effects , Signal Transduction/genetics , Stromal Cells/drug effects , Young Adult
9.
Arch Gynecol Obstet ; 299(2): 489-499, 2019 02.
Article in English | MEDLINE | ID: mdl-30523440

ABSTRACT

PURPOSE: Superficial peritoneal endometriotic (pEM) lesions are composed of endometrial glands and stroma, in addition to a third component-myofibroblasts and smooth muscles (SM)-like cells. The latter develops secondary to a metaplasia. In this study, we characterised the third component cells in pEM according to differentiation markers in different micro-compartments. Furthermore, a possible effect of TGFß1 on myofibroblastic metaplasia in endometriotic epithelial cells was studied. METHODS: Seventy-six premenopausal patients were included. Peritoneal biopsies were excised from EM patients (n = 23), unaffected peritoneum (peritoneum from EM patients but without EM components, n = 5/23) and non-EM patients (n = 10). All peritoneal biopsies were immunolabeled for ASMA, calponin, collagen I, desmin, TGFß receptor 1 (R1), R2 and R3 in addition to ultrastructure examination by transmission electron microscopy (TEM) (n = 1). TGFß1 level was measured in peritoneal fluid (PF) (EM, n = 19 and non-EM, n = 13) collected during laparoscopy. Furthermore, TGFß1 effect on myofibroblastic metaplasia was studied in vitro. RESULTS: At the centre of pEM lesions, calponin immunolabeling outweighs the collagen I while in the periphery the reverse occurs. SM-like cells expressing desmin predominate at the periphery, while ASMA immunolabeling was detectable in all micro-compartments. Both indicate an abundance of myofibroblasts at the centre of pEM lesions and SM-like cells in the periphery. Although activated TGFß1 in PF did not differ between EM and non-EM, it inhibited the cell proliferation of the endometriotic epithelial cells and induced an upregulation in ASMA and collagen IA2 expression as well. CONCLUSION: The abundance of the myofibroblasts and SM-like cells points to a myofibroblastic metaplasia in pEM. Both cells are differentially arranged in the different micro-compartments of pEM lesions, with increasing cell maturity towards the periphery of the lesion. Furthermore, TGFß1 may play a role in the myofibroblastic metaplasia of the endometriotic epithelial cells. These findings provide a better insight in the micro-milieu in EM lesions, where most of the disease dynamics occur.


Subject(s)
Endometriosis/physiopathology , Muscle, Smooth/metabolism , Myofibroblasts/metabolism , Peritoneal Diseases/physiopathology , Peritoneum/physiopathology , Transforming Growth Factor beta1/metabolism , Adult , Cell Differentiation , Female , Humans , Metaplasia
11.
J Gastrointest Surg ; 21(10): 1713-1722, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28685387

ABSTRACT

Postoperative adhesions remain one of the more challenging issues in surgical practice. Although peritoneal adhesions occur after every abdominal operation, the density, time interval to develop symptoms, and clinical presentation are highly variable with no predictable patterns. Numerous studies have investigated the pathophysiology of postoperative adhesions both in vitro and in vivo. Factors such as type and location of adhesions, as well as timing and recurrence of adhesive obstruction remain unpredictable and poorly understood. Although the majority of postoperative adhesions are clinically silent, the consequences of adhesion formation can represent a lifelong problem including chronic abdominal pain, recurrent intestinal obstruction requiring multiple hospitalizations, and infertility. Moreover, adhesive disease can become a chronic medical condition with significant morbidity and no effective therapy. Despite recent advances in surgical techniques, there is no reliable strategy to manage postoperative adhesions. We herein review the pathophysiology and clinical significance of postoperative adhesions while highlighting current techniques of prevention and treatment.


Subject(s)
Abdomen/surgery , Peritoneal Diseases/etiology , Postoperative Complications , Tissue Adhesions/etiology , Humans , Peritoneal Diseases/diagnosis , Peritoneal Diseases/physiopathology , Peritoneal Diseases/therapy , Postoperative Complications/diagnosis , Postoperative Complications/physiopathology , Postoperative Complications/therapy , Tissue Adhesions/diagnosis , Tissue Adhesions/physiopathology , Tissue Adhesions/therapy
12.
J Pathol ; 243(2): 137-147, 2017 10.
Article in English | MEDLINE | ID: mdl-28722107

ABSTRACT

The peritoneum defines a confined microenvironment, which is stable under normal conditions, but is exposed to the damaging effect of infections, surgical injuries, and other neoplastic and non-neoplastic events. Its response to damage includes the recruitment, proliferation, and activation of a variety of haematopoietic and stromal cells. In physiological conditions, effective responses to injuries are organized; inflammatory triggers are eliminated; inflammation quickly abates; and the normal tissue architecture is restored. However, if inflammatory triggers are not cleared, fibrosis or scarring occurs and impaired tissue function ultimately leads to organ failure. Autoimmune serositis is characterized by the persistence of self-antigens and a relapsing clinical pattern. Peritoneal carcinomatosis and endometriosis are characterized by the persistence of cancer cells or ectopic endometrial cells in the peritoneal cavity. Some of the molecular signals orchestrating the recruitment of inflammatory cells in the peritoneum have been identified in the last few years. Alternative activation of peritoneal macrophages was shown to guide angiogenesis and fibrosis, and could represent a novel target for molecular intervention. This review summarizes current knowledge of the alterations to the immune response in the peritoneal environment, highlighting the ambiguous role played by persistently activated reparative macrophages in the pathogenesis of common human diseases. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


Subject(s)
Peritoneal Diseases/physiopathology , Peritoneum/physiology , Autoimmune Diseases/etiology , Endometriosis/etiology , Endometriosis/immunology , Endometriosis/physiopathology , Female , Humans , Immunity, Cellular/physiology , Peritoneal Diseases/etiology , Peritoneal Diseases/immunology , Peritoneal Fibrosis/etiology , Peritoneal Fibrosis/immunology , Peritoneal Fibrosis/physiopathology , Peritoneal Neoplasms/etiology , Peritoneal Neoplasms/immunology , Peritoneal Neoplasms/physiopathology , Peritoneum/anatomy & histology , Peritoneum/immunology , Peritonitis/etiology , Peritonitis/pathology , Peritonitis/physiopathology , Serositis/etiology , Wound Healing/physiology
13.
Clin Biomech (Bristol, Avon) ; 41: 82-86, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28012304

ABSTRACT

BACKGROUND: Adhesion grades and adhesion breaking strength are widely used to assess severity of intraperitoneal adhesion in animal models. However, the results of adhesion grades have the large deviations due to vary personal experience. Adhesion breaking strength ignores the details of adhesion. This study introduced work of separation, the energy consumption during breakage of adhesion, to better evaluate intraperitoneal adhesion. METHODS: The intraperitoneal adhesion was induced by traumas created at rat cecum and adjacent abdominal wall. The wounds were coated with or without sodium hyaluronate. On day 14 after surgery, the intraperitoneal adhesion was assessed by adhesion density grade, adhesion area grade, adhesion breaking strength and work of separation. The healing of parietal peritoneum was evaluated with histology, adhesion breaking strength and work of separation. FINDINGS: The severity of adhesion evaluated with work of separation was consistent with those obtained from the grades of adhesion density, adhesion area and adhesion breaking strength. Work of separation had a linear correlation with adhesion breaking strength. Furthermore, the results of histological examination and work of separation demonstrated that adhesion significantly delayed healing process of abdominal wall muscles. INTERPRETATION: Work of separation can quantify all intraperitoneal adhesions rather than the major one by other methods. It is a more precise method to evaluate postoperative adhesions, especially those including adipose tissue. This study proved that work of separation could be a reliable method to assess intraperitoneal adhesion and tissue healing.


Subject(s)
Peritoneal Diseases/physiopathology , Wound Healing/physiology , Abdominal Wall/physiopathology , Animals , Disease Models, Animal , Female , Humans , Hyaluronic Acid , Peritoneal Diseases/pathology , Rats, Sprague-Dawley , Tissue Adhesions/physiopathology
14.
Eur J Obstet Gynecol Reprod Biol ; 209: 39-43, 2017 Feb.
Article in English | MEDLINE | ID: mdl-26700500

ABSTRACT

OBJECTIVE: To assess the impact of endometriosis of the posterior cul-de-sac on quality of sleep, average daytime sleepiness and insomnia. STUDY DESIGN: This age-matched case-control study was conducted in a tertiary referral centre for the diagnosis and treatment of endometriosis between May 2012 and December 2013. It included 145 women with endometriosis of the posterior cul-de-sac (cases; group E) and 145 patients referred to our Institution because of routine gynaecologic consultations (controls; group C). This study investigated whether sleep is impaired in patients with endometriosis of the posterior cul-de-sac. Sleep quality, daytime sleepiness and insomnia were assessed using the following self-administered questionnaires: the Pittsburgh Sleep Quality Index, the Epworth sleepiness scale and the Insomnia Severity Index, respectively. The primary objective of the study was to evaluate sleep quality in the two study groups. Secondary outcomes of the study were to assess average daytime sleepiness and insomnia in the two study groups. RESULTS: The prevalence of poor sleep quality was significantly higher in group E (64.8%) than in group C (15.1%; p<0.001). The prevalence of excessive daytime sleepiness was significantly higher in group E (23.4%) than in group C (12.9%; p=0.033). Patients of group E experienced subthreshold insomnia (29.0%) and moderate clinical insomnia (16.6%) significantly more frequently than patients in group C (24.4% and 5.0%; p=0.002). CONCLUSION: A substantial proportion of women with endometriosis of the posterior cul-de-sac experiences poor sleep quality, excessive daytime sleepiness and insomnia.


Subject(s)
Douglas' Pouch/pathology , Endometriosis/epidemiology , Peritoneal Diseases/epidemiology , Sleep Initiation and Maintenance Disorders/epidemiology , Sleep Wake Disorders/epidemiology , Sleep/physiology , Adult , Case-Control Studies , Comorbidity , Endometriosis/pathology , Endometriosis/physiopathology , Female , Humans , Peritoneal Diseases/pathology , Peritoneal Diseases/physiopathology , Prevalence , Severity of Illness Index , Sleep Initiation and Maintenance Disorders/diagnosis , Sleep Initiation and Maintenance Disorders/physiopathology , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/physiopathology , Surveys and Questionnaires
15.
BMJ Case Rep ; 20162016 Dec 23.
Article in English | MEDLINE | ID: mdl-28011890

ABSTRACT

A 35-year-old man with a 12-year history of idiopathic myelofibrosis (IMF) presented in 2014 with fatigue and abdominal distension. CT scan revealed massive hepatosplenomegaly with focal splenic lesions, soft tissue around renal pelvis, mesenteric masses compressing bowel loops and perilymphatic nodules in lungs. There was portal hypertension, ascites, pleural effusion, bilateral psoas abscesses and necrotic retroperitoneal lymphadenopathy. MRI additionally revealed hypointense periportal infiltrative lesions in liver, not seen on CT scan. None of these lesions showed diffusion restriction. Biopsy from mesenteric masses revealed extramedullary haematopoeisis. Aspiration from psoas abscess confirmed tuberculosis. Follow-up after 6 weeks of ruxolitinib (JAK2 tyrosine kinase inhibitor) and 9 months of antitubercular therapy revealed resolution of psoas abscesses and lymph nodes. Mild reduction was noted in mesenteric masses and ascites while perirenal soft tissue had increased. Follow-up imaging after another 1 year of ruloxitinib showed new-onset bilateral paravertebral and presacral foci of extramedullary haematopoeisis.


Subject(s)
Hematopoiesis, Extramedullary/physiology , Hypertension, Portal/complications , Primary Myelofibrosis/complications , Tuberculosis, Lymph Node/complications , Adult , Diagnosis, Differential , Hepatomegaly/etiology , Hepatomegaly/physiopathology , Humans , Kidney Diseases/physiopathology , Lung Diseases/physiopathology , Magnetic Resonance Imaging , Male , Peritoneal Diseases/physiopathology , Primary Myelofibrosis/diagnosis , Splenomegaly/etiology , Splenomegaly/physiopathology , Tomography, X-Ray Computed
16.
Eur J Obstet Gynecol Reprod Biol ; 197: 36-40, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26704015

ABSTRACT

OBJECTIVE: The aim of the current study was to evaluate the effect of surgical removal of endometriosis on dyspareunia, sexual function, quality of sex life and interpersonal relationships. STUDY DESIGN: A questionnaire-based multicentre prospective study was conducted in six tertiary referral centres in Austria and Germany. Ninety-six patients with histologically proven endometriosis and dyspareunia were included. Before surgery and averagely 10 months postoperatively (range 9-12 months), the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS) were used to screen women's sexuality. Additionally, we evaluated psychological parameters and pain intensity during/after sexual intercourse via a self-administered questionnaire. RESULTS: Pain scores measured via NAS during/after intercourse decreased significantly after surgery. Frequencies of interrupted sexual intercourse, feelings of guilt towards the partner, being afraid of pain before/during sexual intercourse and feelings of being a burden for the relationship also decreased significantly in patients with peritoneal endometriosis and deep infiltrating endometriosis. Interestingly, sexually related personal distress did not improve in women with peritoneal endometriosis/vaginal resection, but improved in cases of deep infiltrating endometriosis (DIE). CONCLUSION: Radical laparoscopic excision of endometriosis offers an effective treatment option and offers a significant improvement in dyspareunia and quality of sex life.


Subject(s)
Dyspareunia/physiopathology , Endometriosis/surgery , Peritoneal Diseases/surgery , Sexual Behavior , Sexual Dysfunctions, Psychological/physiopathology , Vaginal Diseases/surgery , Adolescent , Adult , Austria , Dyspareunia/complications , Dyspareunia/psychology , Endometriosis/complications , Endometriosis/physiopathology , Female , Germany , Humans , Interpersonal Relations , Laparoscopy , Middle Aged , Peritoneal Diseases/complications , Peritoneal Diseases/physiopathology , Personal Satisfaction , Prospective Studies , Sexual Dysfunction, Physiological/complications , Sexual Dysfunction, Physiological/physiopathology , Sexual Dysfunction, Physiological/psychology , Sexual Dysfunctions, Psychological/complications , Sexual Dysfunctions, Psychological/psychology , Surveys and Questionnaires , Treatment Outcome , Vaginal Diseases/complications , Vaginal Diseases/physiopathology , Young Adult
17.
Lancet Gastroenterol Hepatol ; 1(3): 238-247, 2016 11.
Article in English | MEDLINE | ID: mdl-28404096

ABSTRACT

Systematic study of the mesentery is now possible because of clarification of its structure. Although this area of science is in an early phase, important advances have already been made and opportunities uncovered. For example, distinctive anatomical and functional features have been revealed that justify designation of the mesentery as an organ. Accordingly, the mesentery should be subjected to the same investigatory focus that is applied to other organs and systems. In this Review, we summarise the findings of scientific investigations of the mesentery so far and explore its role in human disease. We aim to provide a platform from which to direct future scientific investigation of the human mesentery in health and disease.


Subject(s)
Mesentery , Peritoneal Diseases , Humans , Mesentery/anatomy & histology , Mesentery/pathology , Mesentery/physiology , Mesentery/physiopathology , Peritoneal Diseases/diagnosis , Peritoneal Diseases/pathology , Peritoneal Diseases/physiopathology , Peritoneal Diseases/therapy
19.
Arch Gynecol Obstet ; 292(4): 869-73, 2015 Oct.
Article in English | MEDLINE | ID: mdl-25877224

ABSTRACT

PURPOSE: The aim of this study is to evaluate prospectively the presence of endometriosis in the peritoneum of the ovarian fossa of patients affected by endometriomas and its correlation with the adhesion between this peritoneum and endometrioma. METHODS: Patients presenting ovarian endometriomas and candidate to laparoscopy were considered for inclusion in the study. Patients underwent laparoscopic excision of endometriomas. The presence of adherence of the ovarian fossa to endometrioma was investigated. In all patients, the removal of a peritoneum fragment from the ovarian fossa of the affected ovary was carried out. RESULTS: 68 patients were enrolled in the study. 48 patients presented adhesions to the ovarian fossa. Histopathologic examination of the peritoneum of the ovarian fossa revealed the presence of endometriosis in 87 % of patients presenting adhesions of the endometriomas with ovarian fossa; surprisingly it was present only in 15 % of patients not presenting this condition (p < 0.0001). Pain symptoms were more frequent in patients with endometriomas adhesion to the ovarian fossa. CA125 levels were not statistically significantly different between groups. At 12-month follow-up, four patients presented endometrioma recurrence. All of them presented adhesion of the ovarian fossa to the endometrioma in the first operation. CONCLUSIONS: There is a strong association between adhesion of the endometriomas to the ovarian fossa and the presence of endometriosis on the peritoneal surface of the fossa. This condition significantly correlates with pain symptoms and may predict endometrioma recurrence. The removal of this peritoneum in case of adherent endometrioma may potentially reduce the incidence of recurrence.


Subject(s)
Endometriosis/physiopathology , Laparoscopy , Ovarian Diseases/pathology , Peritoneal Diseases/physiopathology , Peritoneum/pathology , Adolescent , Adult , Endometriosis/complications , Endometriosis/surgery , Female , Follow-Up Studies , Humans , Middle Aged , Ovarian Diseases/complications , Ovarian Diseases/surgery , Ovary/pathology , Pain Measurement , Peritoneal Diseases/complications , Peritoneal Diseases/surgery , Prospective Studies , Recurrence , Tissue Adhesions/pathology
20.
Chirurg ; 86(2): 175-80, 2015 Feb.
Article in German | MEDLINE | ID: mdl-25673225

ABSTRACT

Postoperative peritoneal adhesions are common sequelae of abdominal surgery. Acute as well as chronic complications, including bowel obstruction, abdominal pain and infertility can arise from adhesion formation. So far, the only reliable treatment is surgical adhesiolysis, which in turn is accompanied by an increased risk of adhesion recurrence. Despite significant progress in modern perioperative medicine, only limited prophylactic approaches are available and atraumatic surgery is still the most important factor.Current research concepts focus on two major antiadhesion strategies: firstly, the intraoperative placement of mechanical barriers and secondly novel immunomodulation concepts. Clinical data about the use of antiadhesive barriers show a heterogeneous outcome. Promising data have arisen from the immunomodulatory approaches and now require a step-up development from experimental to clinical trial level.The present review gives a short overview about the current research on the pathophysiology and prevention of peritoneal adhesions. The promising data are encouraging and require realization of carefully designed prospective clinical trials.


Subject(s)
Peritoneal Diseases/prevention & control , Postoperative Complications/prevention & control , Animals , Epithelium/physiopathology , Humans , Laparoscopy , Peritoneal Diseases/complications , Peritoneal Diseases/physiopathology , Peritoneal Diseases/surgery , Postoperative Complications/physiopathology , Postoperative Complications/surgery , Research , Risk Factors , Tissue Adhesions/complications , Tissue Adhesions/physiopathology , Tissue Adhesions/prevention & control , Tissue Adhesions/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...